Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway.
Jin Y, Yang Q, Liang L, Ding L, Liang Y, Zhang D, Wu B, Yang T, Liu H, Huang T, Shen H, Tu H, Pan Y, Wei Y, Yang Y, Zhou F.
Jin Y, et al. Among authors: wei y.
J Exp Clin Cancer Res. 2018 Nov 19;37(1):277. doi: 10.1186/s13046-018-0948-3.
J Exp Clin Cancer Res. 2018.
PMID: 30454068
Free PMC article.